218 related articles for article (PubMed ID: 6086410)
21. Agonists differentiate muscarinic receptors that inhibit cyclic AMP formation from those that stimulate phosphoinositide metabolism.
Brown JH; Brown SL
J Biol Chem; 1984 Mar; 259(6):3777-81. PubMed ID: 6323440
[TBL] [Abstract][Full Text] [Related]
22. Muscarinic receptors and their regulation of cyclic GMP in corneal endothelial cells.
Walkenbach RJ; Ye GS
Invest Ophthalmol Vis Sci; 1990 Apr; 31(4):702-7. PubMed ID: 2159450
[TBL] [Abstract][Full Text] [Related]
23. Cyclic GMP-dependent protein kinase activation in the absence of negative inotropic effects in the rat ventricle.
MacDonell KL; Diamond J
Br J Pharmacol; 1997 Dec; 122(7):1425-35. PubMed ID: 9421291
[TBL] [Abstract][Full Text] [Related]
24. Muscarinic cholinergic agonists stimulate arachidonic acid release from mouse striatal neurons in primary culture.
Tencé M; Cordier J; Premont J; Glowinski J
J Pharmacol Exp Ther; 1994 May; 269(2):646-53. PubMed ID: 8182531
[TBL] [Abstract][Full Text] [Related]
25. Adrenergic-cholinergic interactions in left atria: interaction of carbachol with alpha- and beta-adrenoceptor agonists.
MacLeod KM
Can J Physiol Pharmacol; 1986 May; 64(5):597-601. PubMed ID: 2873880
[TBL] [Abstract][Full Text] [Related]
26. Pertussis toxin-insensitive phosphoinositide hydrolysis, membrane depolarization, and positive inotropic effect of carbachol in chick atria.
Tajima T; Tsuji Y; Brown JH; Pappano AJ
Circ Res; 1987 Sep; 61(3):436-45. PubMed ID: 3040295
[TBL] [Abstract][Full Text] [Related]
27. Cholinergic stimulation of phosphoinositide hydrolysis in renal medullary collecting duct cells.
McArdle S; Garg LC
J Pharmacol Exp Ther; 1989 Feb; 248(2):682-6. PubMed ID: 2537409
[TBL] [Abstract][Full Text] [Related]
28. Ca2+ inhibition of beta-adrenergic receptor- and forskolin-stimulated cAMP accumulation in C6-2B rat glioma cells is independent of protein kinase C.
Debernardi MA; Munshi R; Brooker G
Mol Pharmacol; 1993 Mar; 43(3):451-8. PubMed ID: 8383803
[TBL] [Abstract][Full Text] [Related]
29. Activation and blockade of cardiac muscarinic receptors by endogenous acetylcholine and cholinesterase inhibitors.
Brown JH; Wetzel GT; Dunlap J
J Pharmacol Exp Ther; 1982 Oct; 223(1):20-4. PubMed ID: 6288918
[TBL] [Abstract][Full Text] [Related]
30. Muscarinic receptor stimulated phosphoinositide turnover in cardiac atrial tissue.
Quist EE; Satumtira N
Biochem Pharmacol; 1987 Feb; 36(4):499-505. PubMed ID: 3030327
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms involved in the regulation of mRNA for M2 muscarinic acetylcholine receptors and endothelial and neuronal NO synthases in rat atria.
Ganzinelli S; Joensen L; Borda E; Bernabeo G; Sterin-Borda L
Br J Pharmacol; 2007 May; 151(2):175-85. PubMed ID: 17384670
[TBL] [Abstract][Full Text] [Related]
32. Specific Gq protein involvement in muscarinic M3 receptor-induced phosphatidylinositol hydrolysis and Ca2+ release in mouse duodenal myocytes.
Morel JL; Macrez N; Mironneau J
Br J Pharmacol; 1997 Jun; 121(3):451-8. PubMed ID: 9179386
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of muscarinic modulation of protein phosphorylation in intact ventricles.
Watanabe AM; Lindemann JP; Fleming JW
Fed Proc; 1984 Aug; 43(11):2618-23. PubMed ID: 6086411
[TBL] [Abstract][Full Text] [Related]
34. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
Olianas MC; Maullu C; Onali P
Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
[TBL] [Abstract][Full Text] [Related]
35. Modulation of spasmogen-stimulated Ins(1,4,5)P3 generation and functional responses by selective inhibitors of types 3 and 4 phosphodiesterase in airways smooth muscle.
Challiss RA; Adams D; Mistry R; Nicholson CD
Br J Pharmacol; 1998 May; 124(1):47-54. PubMed ID: 9630342
[TBL] [Abstract][Full Text] [Related]
36. The porcine heart M2 muscarinic receptor: agonist-induced phosphorylation and comparison of properties with the chick heart receptor.
Kwatra MM; Ptasienski J; Hosey MM
Mol Pharmacol; 1989 May; 35(5):553-8. PubMed ID: 2725467
[TBL] [Abstract][Full Text] [Related]
37. Relationships between phosphoinositide and calcium responses to muscarinic agonists in astrocytoma cells.
Masters SB; Harden TK; Brown JH
Mol Pharmacol; 1984 Sep; 26(2):149-55. PubMed ID: 6090879
[TBL] [Abstract][Full Text] [Related]
38. Stimulant effects of muscarinic agonists in embryonic chick ventricular muscle. Are the effects mediated by protein kinase C?
Mubagwa K; Vites AM; Pappano AJ
J Pharmacol Exp Ther; 1992 Mar; 260(3):1323-30. PubMed ID: 1312167
[TBL] [Abstract][Full Text] [Related]
39. Comparison of muscarinic and alpha-adrenergic receptors in rat atria based on phosphoinositide turnover.
Sekar MC; Roufogalis BD
Life Sci; 1984 Oct; 35(14):1527-33. PubMed ID: 6090840
[TBL] [Abstract][Full Text] [Related]
40. Pertussis toxin does not inhibit muscarinic-receptor-mediated phosphoinositide hydrolysis or calcium mobilization.
Masters SB; Martin MW; Harden TK; Brown JH
Biochem J; 1985 May; 227(3):933-7. PubMed ID: 2988509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
